Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition.
Saved in:
| Title: | Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition. |
|---|---|
| Authors: | Huynh MV; Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Parsonage D; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Forshaw TE; Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Chirasani VR; Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hobbs GA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Wu H; Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Lee J; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA., Furdui CM; Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA; Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Poole LB; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA; Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Electronic address: lbpoole@wakehealth.edu., Campbell SL; Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: campbesl@med.unc.edu. |
| Source: | The Journal of biological chemistry [J Biol Chem] 2022 Aug; Vol. 298 (8), pp. 102186. Date of Electronic Publication: 2022 Jun 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35753348 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Huynh+MV%22">Huynh MV</searchLink>; Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Parsonage+D%22">Parsonage D</searchLink>; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Forshaw+TE%22">Forshaw TE</searchLink>; Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Chirasani+VR%22">Chirasani VR</searchLink>; Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Hobbs+GA%22">Hobbs GA</searchLink>; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Furdui+CM%22">Furdui CM</searchLink>; Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA; Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Poole+LB%22">Poole LB</searchLink>; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, USA; Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Electronic address: lbpoole@wakehealth.edu.<br /><searchLink fieldCode="AU" term="%22Campbell+SL%22">Campbell SL</searchLink>; Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Electronic address: campbesl@med.unc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985121R%22">The Journal of biological chemistry</searchLink> [J Biol Chem] 2022 Aug; Vol. 298 (8), pp. 102186. <i>Date of Electronic Publication: </i>2022 Jun 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%2E+on+behalf+of+American+Society+for+Biochemistry+and+Molecular+Biology%22">Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985121R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1083-351X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219258%22">00219258 </searchLink><i>NLM ISO Abbreviation: </i>J Biol Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35753348 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jbc.2022.102186 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102186 Titles: – TitleFull: Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Huynh MV – PersonEntity: Name: NameFull: Parsonage D – PersonEntity: Name: NameFull: Forshaw TE – PersonEntity: Name: NameFull: Chirasani VR – PersonEntity: Name: NameFull: Hobbs GA – PersonEntity: Name: NameFull: Wu H – PersonEntity: Name: NameFull: Lee J – PersonEntity: Name: NameFull: Furdui CM – PersonEntity: Name: NameFull: Poole LB – PersonEntity: Name: NameFull: Campbell SL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1083-351X Numbering: – Type: volume Value: 298 – Type: issue Value: 8 Titles: – TitleFull: The Journal of biological chemistry Type: main |
| ResultId | 1 |